<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - CanSino Biologics Ramps Up Vaccine Production During Phase III Trials
Image Overlay - CanSino Biologics Ramps Up Vaccine Production During Phase III Trials

CanSino Biologics Ramps Up Vaccine Production During Phase III Trials

September 28, 2020

CanSino Biologics Ramps Up Vaccine Production During Phase III Trials

Chinese company CanSino Biologics Inc has plans to ramp up production of their COVID-19 vaccine following the completion of Phase III clinical trials. The company plans to produce 300 million doses a year. Yourway has a 11,700 square foot local depot located in Beijing, China and has capacity globally to help facilitate clinical trials anywhere.

 Back to Index
Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

Clinical Trial Supply New England

April 14-15, 2026
Boston, MA

GCSG 2026 US Conference

April 27-29, 2026
San Diego, CA

Media

Articles

White-Glove by Design: The Yourway Standard in Clinical Logistics

Open chat
Come chat with us!
Hello! How can I help you?